NEA Management Company, LLC Q2 2018 Filing
Filed August 9, 2018
Portfolio Value
$2.1T
Holdings
43
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TESARO INC | 10,420,555 | $463.4B | 21.71% | |
| 2 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 13,332,611 | $158.3B | 7.41% | |
| 3 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $153.6B | 7.19% | |
| 4 | GLYCEURGLYCOMIMETICS INC | 9,089,041 | $146.6B | 6.87% | |
| 5 | —MERSANA THERAPEUTICS INC | 8,144,267 | $145.5B | 6.81% | |
| 6 | SENS1GBPSENSEONICS HOLDINGS INC | 30,888,266 | $127.0B | 5.95% | |
| 7 | CRSPCRISPR THERAPEUTICS AG | 2,090,678 | $122.8B | 5.76% | |
| 8 | —EPIZYME INC | 6,460,851 | $87.5B | 4.10% | |
| 9 | —OBSEVA SA | 4,586,563 | $69.4B | 3.25% | |
| 10 | ARDXARDELYX INC | 15,335,047 | $56.7B | 2.66% | |
| 11 | —RA PHARMACEUTICALS INC | 5,493,636 | $54.7B | 2.56% | |
| 12 | SURFUSDSURFACE ONCOLOGY INC | 3,315,149 | $54.1B | 2.53% | |
| 13 | —ACHAOGEN INC | 5,215,128 | $45.2B | 2.12% | |
| 14 | —SYNLOGIC INC | 4,229,410 | $41.6B | 1.95% | |
| 15 | —AVEO PHARMACEUTICALS INC | 17,783,722 | $40.1B | 1.88% | |
| 16 | —DERMIRA INC | 3,506,649 | $32.3B | 1.51% | |
| 17 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $28.6B | 1.34% | |
| 18 | —CLEMENTIA PHARMACEUTICALS IN | 2,141,697 | $28.2B | 1.32% | |
| 19 | AUPHAURINIA PHARMACEUTICALS INC | 4,808,483 | $27.1B | 1.27% | |
| 20 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $24.8B | 1.16% | |
| 21 | MEIPUSDMEI PHARMA INC | 5,720,572 | $22.5B | 1.06% | |
| 22 | —GENOCEA BIOSCIENCES INC | 25,000,000 | $21.3B | 1.00% | |
| 23 | CTIC1USDCTI BIOPHARMA CORP | 3,750,000 | $18.7B | 0.87% | |
| 24 | VRNAVERONA PHARMA PLC | 1,219,674 | $16.7B | 0.78% | |
| 25 | —PROTEOSTASIS THERAPEUTICS INC | 5,556,778 | $15.5B | 0.73% | |
| 26 | —ENDOLOGIX INC | 2,490,204 | $14.1B | 0.66% | |
| 27 | —ARQULE INC | 2,520,316 | $13.9B | 0.65% | |
| 28 | —NIGHTSTAR THERAPEUTICS PLC | 714,285 | $11.4B | 0.54% | |
| 29 | CSBRCHAMPIONS ONCOLOGY INC | 1,562,500 | $9.9B | 0.46% | |
| 30 | —TRACON PHARMACEUTICALS INC | 3,467,181 | $9.4B | 0.44% | |
| 31 | —DASAN ZHONE SOLUTIONS INC | 956,255 | $9.3B | 0.44% | |
| 32 | RIGLUSDRIGEL PHARMACEUTICALS INC | 3,243,150 | $9.2B | 0.43% | |
| 33 | —AFFIMED NV | 5,138,888 | $8.5B | 0.40% | |
| 34 | TREURTRILLIUM THERAPEUTICS INC | 1,250,000 | $7.5B | 0.35% | |
| 35 | MDBMONGODB INC | 150,000 | $7.4B | 0.35% | |
| 36 | —ARSANIS INC | 2,000,000 | $7.3B | 0.34% | |
| 37 | —REGULUS THERAPEUTICS INC | 10,989,910 | $7.2B | 0.34% | |
| 38 | ERYP1EURERYTECH PHARMA SA | 625,000 | $7.0B | 0.33% | |
| 39 | —TREVENA INC | 3,811,691 | $5.5B | 0.26% | |
| 40 | —SUNESIS PHARMACEUTICALS INC | 1,298,274 | $2.8B | 0.13% | |
| 41 | —TINTRI INC | 5,253,358 | $1.3B | 0.06% | |
| 42 | —AKARI THERAPEUTICS PLC | 452,167 | $882.0M | 0.04% | |
| 43 | —AYTU BIOSCIENCE INC | 44,908 | $12.0M | 0.00% |